Capsule retractors improve challenge of weak zonules during cataract surgery
April 15th 2015Weak zonules are known to add intraoperative complications and affect every step of the cataract procedure. Luigi Fontana, MD, PhD, describes how capsule retractors have helped him tackle this issue in his cataract practice.
Contrast sensitivity metrics extend beyond measure of vision
April 15th 2015Contrast sensitivity is a more valuable metric than many ophthalmologists realize, with applications in preoperative and postoperative management of corneal and refractive surgery patients and routine screening of patients’ quality of vision.
Retinal gene therapy advancing into clinical reality
April 15th 2015Gene therapy can provide transformative disease-modifying effects, with potentially lifelong clinical benefits after a single therapeutic administration. The most advanced retinal gene therapy program in the United States is in phase III study.
Antique book collection brings ophthalmic history to life
April 15th 2015The American Academy has acquired the Spencer E. Sherman, M.D. Antique Ophthalmology Book Collection. This collection consists of more than 130 rare books and catalogs, representing some of the oldest and most important texts ever published in ophthalmology.
Palinopsia Peeking behind doors of visual perception, visual memory
April 15th 2015Palinopsia can be broadly defined as the persistence or recurrence of an image after the stimulus has been removed. Formed, high-resolution afterimages are typically more alarming to patients than unformed, blurred afterimages.
Dysfunctional lens syndrome paradox
April 11th 2015In his latest blog, Mark Packer, MD, FACS, CPI, defends why doctors should not allow the restrictions of third party payers on reimbursement for cataract surgery to drive your diagnosis or your recommendations for treatment, as diagnosis and treatment must remain the surgeon’s sole responsibility if our profession is to retain any of its natural inherent authority.
Novartis deterred UK physicians from prescribing Avastin, report says
April 7th 2015Novartis attempted to block studies in the United Kingdom comparing ranibizumab (Lucentis) and bevacizumab (Avastin) for the treatment of wet age-related macular degeneration (AMD), according to an article published in The BJM, an international peer-reviewed medical journal.
Pain without stain poses diagnostic and therapeutic dilemma
April 1st 2015Keratoneuralgia, also known as “pain without stain” is primarily a clinical diagnosis made for patients with corneal pain symptoms with minimal-to-no clinical signs and minimally, if at all, relieved by conventional dry eye treatments.
Novel anti-VEGF agent approved in China may reduce injection frequency
April 1st 2015Conbercept is an anti-vascular endothelial growth factor (VEGF) drug approved for the treatment of wet age-related macular degeneration in China. Compared with agents used in the United States, it has a higher binding affinity, lower VEGF dissociation rate, and longer clearance time.